Home & Ambulatory Infusion is categorized under Home Health Care Services in Eureka, CA and active since 2003.
Home & Ambulatory Infusion was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Tim Talbert, Director at the company’s single location by writing to 2612 Harrison Avenue, Eureka, California CA 95501 or by phoning (707) 269-4258. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Home & Ambulatory Infusion |
| Contact Person: | Tim Talbert, Director |
| Address: | 2612 Harrison Avenue, Eureka, California 95501 |
| Phone Number: | (707) 269-4258 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Home Health Care Services |
| SIC Code: | 8082 |
| NAICS Code: | 6216100 |
| Share This Business: |
Home & Ambulatory Infusion was started in 2003 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Tim Talbert, Director for inquiries that concern Home & Ambulatory Infusion by calling the company number (707) 269-4258, as your correspondence is most welcome. Additionally, the physical location of the single location of Home & Ambulatory Infusion can be found at the coordinates 40.78426,-124.13975 as well as the street address 2612 Harrison Avenue in Eureka, California 95501.
For its online presence, you may visit Home & Ambulatory Infusion’s website at and engage with its social media outlets through on Twitter and on Facebook.